List View Detail View 276-300 of 332 items Sort by: Best Match Name Clone Applications Regulatory Status Previous 1 ... 11 12 13 ... 14 Next Product Clone Appl. Reg Cat# Size Price Quantity Purified anti-human CD224 Antibody KF29 FC RUO 394302 100 µg £182 TotalSeq™-A1052 anti-human CD224 Antibody KF29 PG RUO 394311 10 µg £253 TotalSeq™-B1052 anti-human CD224 Antibody KF29 PG RUO 394309 10 µg £253 TotalSeq™-C1052 anti-human CD224 Antibody KF29 PG RUO 394307 10 µg £253 Biotin anti-mouse CD229 (Ly-9) Antibody Ly9ab3 FC RUO 122903 50 µg £57 Purified anti-mouse CD229 (Ly-9) Antibody Ly9ab3 FC RUO 122901 50 µg £49 FITC anti-human CD222 (IGF2R) Recombinant Antibody QA19A18 ICFC, FC RUO 364207 25 tests £53 364208 100 tests £121 APC anti-human CD222 (IGF2R) Recombinant Antibody QA19A18 ICFC, FC RUO 364205 25 tests £65 364206 100 tests £151 PE anti-human CD222 (IGF2R) Recombinant Antibody QA19A18 ICFC, FC RUO 364203 25 tests £68 364204 100 tests £155 Purified anti-human CD222 (IGF2R) Recombinant Antibody QA19A18 ICFC, FC RUO 364202 100 µg £265 TotalSeq™-B1453 anti-human CD222 (IGF2R) Recombinant Antibody QA19A18 ICPG RUO 364209 10 µg £253 TotalSeq™-C1453 anti-human CD222 (IGF2R) Recombinant Antibody QA19A18 ICPG RUO 364211 10 µg £253 Ultra-LEAF™ Purified anti-mouse CD223 (LAG-3) Recombinant Antibody QA20A93 FC RUO 109703 100 µg £76 109704 1 mg £102 Purified anti-human CD228 (MFI2, MTF1) Antibody SHM72 FC RUO 363101 100 µg £182 FITC anti-human CD226 (DNAM-1) Antibody TX25 FC RUO 337104 100 tests £157 PE anti-human CD226 (DNAM-1) Antibody TX25 FC RUO 337106 100 tests £180 Purified anti-human CD226 (DNAM-1) Antibody TX25 FC RUO 337102 100 µg £85 TotalSeq™-A0805 anti-human CD226 (DNAM-1) Antibody TX25 PG RUO 337111 10 µg £253 TotalSeq™-B0805 anti-human CD226 (DNAM-1) Antibody TX25 PG RUO 337115 10 µg £253 TotalSeq™-C0805 anti-human CD226 (DNAM-1) Antibody TX25 PG RUO 337113 10 µg £253 TotalSeq™-D0805 anti-human CD226 (DNAM-1) Antibody TX25 PG RUO 337117 10 µg £253 Results Per Page: 25 50 100 200 Previous 1 ... 11 12 13 ... 14 Next
Follow Us